IndraLab

Statements

USP36 deubiquitinates PARP1. 2 / 2
| 2
reach
"This investigation provides compelling evidence that USP36 deubiquitinates PARP1, suggesting that the USP36/PARP1 axis is a promising therapeutic target for Dox-induced cardiomyopathy [63] (Figure 2G)."
38785979
reach
"As shown in Fig. 4 A , overexpression of USP36 WT promoted the deubiquitination of PARP1 and increased the levels of PARP1 in HEK293T cells, while the C131A mutant failed to induce PARP1 level."
38307305